Boston Scientific Corporation

BSX

US1011371077

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 18:42:19 17/01/2025 GMT			5-day change	1st Jan Change
98.79 ^USD	+0.63%		+3.92%	+10.38%

06:18pm	Boston Scientific on Track to Be Highest Performing Medtech Firm, RBC Says	MT
01-14	Boston Scientific Corporation Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-13-2025 05:15 PM

Daiwa Securities Adjusts Price Target on Boston Scientific to $94 From $83, Maintains Buy Rating

October 28, 2024 at 01:39 pm

This article is reserved for members

To unlock the article, REGISTER!

100% Free Registration

Already a customer? Log In

Latest news about Boston Scientific Corporation

Boston Scientific on Track to Be Highest Performing Medtech Firm, RBC Says	06:18pm	MT
Boston Scientific Corporation Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-13-2025 05:15 PM	01-14
Baird Adjusts Price Target on Boston Scientific $104 From $102, Keeps Outperform Rating	01-13	MT
Deutsche Bank Upgrades Boston Scientific to Buy From Hold, Raises Price Target to $108 From $87	01-10	MT
Bernstein Adjusts Price Target on Boston Scientific to $110 From $100, Keeps Outperform Rating	01-09	MT
Fed Meeting Minutes Leave Equities Mixed	01-08	MT
Equities Close Mixed After Labor Market Data, Fed Minutes	01-08	MT
Equities Largely Unchanged After Labor Market Data, Fed Governor Remarks	01-08	MT
Stocks in motion: Quantum computing stocks tumble after Nvidia's CEO comment	01-08
Sector Update: Health Care Stocks Rise Premarket Wednesday	01-08	MT
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Wednesday Ahead of FOMC Meeting Minutes	01-08	MT
Boston Scientific to Acquire Remaining Stake in Bolt Medical for $443 Million Plus Milestone Payments	01-08	MT
Boston Scientific to Buy Rest of Bolt Medical for $443 Million	01-08	DJ
Boston Scientific Corporation entered into an agreement to acquire remaining 74% stake in Bolt Medical, Inc.	01-07	CI
ETF contrarian betting: and above all, Health!	01-07
UBS Raises Price Target on Boston Scientific to $105 From $102, Keeps Buy Rating	01-06	MT
Evercore ISI Adjusts Price Target on Boston Scientific to $100 From $95	01-02	MT
Hawkish hints spook investors	12-19
FDA classifies recall of Boston Scientific catheters as 'most serious'	12-18	RE
Baird Raises Boston Scientific Price Target to $102 From $100, Maintains Outperform Rating	12-18	MT
Truist Securities Adjusts Price Target on Boston Scientific to $110 From $100, Keeps Buy Rating	12-18	MT
RBC Raises Price Target on Boston Scientific to $105 From $98, Keeps Outperform Rating	12-18	MT
Goldman Sachs Raises Price Target on Boston Scientific to $103 From $102, Maintains Buy Rating	12-16	MT
Nephron Adjusts Price Target on Boston Scientific to $106 From $102	12-12	MT
TD Cowen Adjusts Price Target on Boston Scientific to $110 From $100, Maintains Buy Rating	12-12	MT

Chart Boston Scientific Corporation

Duration

Period

BSX: Dynamic Chart

Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%); - endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ; - neuromodulation (2%). The United States account for 59.2% of net sales.

Employees

48,000

Sector

Advanced Medical Equipment & Technology

Calendar

05/02/2025 - Q4 2024 Earnings Release

More about the company